eMedDerm Needs Assessment 2010

1. Greetings colleagues

Dear Colleague,

We thank all 2000+ of our loyal subscribers for your readership and look forward to continuing to provide informative newsletters and podcasts.

The following brief FIVE MINUTE survey is intended to assess your need for a continuing medical education activity for 2010-11. The success of eMedicalDermatology Review depends on your valuable input, so please take a few minutes and help us out.

Thank you for your assistance,

BERNARD A. COHEN, MD
Professor of Pediatrics and Dermatology
Director of Pediatric Dermatology
Johns Hopkins Children's Center
Baltimore, MD

Question Title

* 1. Please indicate your specialty:

Dermatology

PharmD

Nurse/Nurse Practitioner

Pediatric Dermatology

Dermasurgeon

Immunodermatology

Wound Care

Other

Question Title

* 2. Over the last year we have covered a number of topics relevant to caring for patients with Medical Dermatologic conditions. Please rate each of the following based on the value of the information presented with respect to clinical practice:

	Extremely Valuable	Very Valuable	Somewhat Valuable	Not Valuable
Atopic Dermatitis – A Disease Caused by a Barrier Defect?	Atopic Dermatitis – A Disease Caused by a Barrier Defect? Extremely Valuable	Atopic Dermatitis – A Disease Caused by a Barrier Defect? Very Valuable	Atopic Dermatitis – A Disease Caused by a Barrier Defect? Somewhat Valuable	Atopic Dermatitis – A Disease Caused by a Barrier Defect? Not Valuable
Melanoma Outcomes Among Solid Organ Transplant Recipients and Controversial Topics in Treatment	Melanoma Outcomes Among Solid Organ Transplant Recipients and Controversial Topics in Treatment Extremely Valuable	Melanoma Outcomes Among Solid Organ Transplant Recipients and Controversial Topics in Treatment Very Valuable	Melanoma Outcomes Among Solid Organ Transplant Recipients and Controversial Topics in Treatment Somewhat Valuable	Melanoma Outcomes Among Solid Organ Transplant Recipients and Controversial Topics in Treatment Not Valuable
Health Implications of Vitamin D	Health Implications of Vitamin D Extremely Valuable	Health Implications of Vitamin D Very Valuable	Health Implications of Vitamin D Somewhat Valuable	Health Implications of Vitamin D Not Valuable
Safety of Biologic Agents	Safety of Biologic Agents Extremely Valuable	Safety of Biologic Agents Very Valuable	Safety of Biologic Agents Somewhat Valuable	Safety of Biologic Agents Not Valuable
Update on the Management of Nail Disorders	Update on the Management of Nail Disorders Extremely Valuable	Update on the Management of Nail Disorders Very Valuable	Update on the Management of Nail Disorders Somewhat Valuable	Update on the Management of Nail Disorders Not Valuable
Fillers	Fillers Extremely Valuable	Fillers Very Valuable	Fillers Somewhat Valuable	Fillers Not Valuable

Question Title

* 3. For each of the following, what changes have you made in your practice, based on information gained from eMedical Dermatology Review?

	Implemented	Plan to Implement	May Implement	Do not Intend to Implement	N/A
Atopic Dermatitis – A Disease Caused by a Barrier Defect?	Atopic Dermatitis – A Disease Caused by a Barrier Defect? Implemented	Atopic Dermatitis – A Disease Caused by a Barrier Defect? Plan to Implement	Atopic Dermatitis – A Disease Caused by a Barrier Defect? May Implement	Atopic Dermatitis – A Disease Caused by a Barrier Defect? Do not Intend to Implement	Atopic Dermatitis – A Disease Caused by a Barrier Defect? N/A
Melanoma Outcomes Among Solid Organ Transplant Recipients and Controversial Topics in Treatment	Melanoma Outcomes Among Solid Organ Transplant Recipients and Controversial Topics in Treatment Implemented	Melanoma Outcomes Among Solid Organ Transplant Recipients and Controversial Topics in Treatment Plan to Implement	Melanoma Outcomes Among Solid Organ Transplant Recipients and Controversial Topics in Treatment May Implement	Melanoma Outcomes Among Solid Organ Transplant Recipients and Controversial Topics in Treatment Do not Intend to Implement	Melanoma Outcomes Among Solid Organ Transplant Recipients and Controversial Topics in Treatment N/A
Health Implications of Vitamin D	Health Implications of Vitamin D Implemented	Health Implications of Vitamin D Plan to Implement	Health Implications of Vitamin D May Implement	Health Implications of Vitamin D Do not Intend to Implement	Health Implications of Vitamin D N/A
Safety of Biologic Agents	Safety of Biologic Agents Implemented	Safety of Biologic Agents Plan to Implement	Safety of Biologic Agents May Implement	Safety of Biologic Agents Do not Intend to Implement	Safety of Biologic Agents N/A
Update on the Management of Nail Disorders	Update on the Management of Nail Disorders Implemented	Update on the Management of Nail Disorders Plan to Implement	Update on the Management of Nail Disorders May Implement	Update on the Management of Nail Disorders Do not Intend to Implement	Update on the Management of Nail Disorders N/A
Fillers	Fillers Implemented	Fillers Plan to Implement	Fillers May Implement	Fillers Do not Intend to Implement	Fillers N/A

Other (please specify)

Question Title

* 4. As we develop our topics for the next volume, how interested are you in learning more about the following subjects:

Question Title

* 5. Please indicate your level of clinical confidence in these topics:

Other (please specify)

Question Title

* 6. What are your preferred learning formats?

Email Based Newsletter

Podcast or audio program (e.g. via computer or iPod)

Printed Media (e.g. monograph or transcript)

Question Title

* 7. Have you listened to our eMedical Dermatology Review podcasts?

Yes and I found it valuable

Yes, but I would not listen again

No, but I plan on listening soon - Really!

No. I won't be listening to the podcasts

If you said "No. I won't be listening to the podcasts" please tell us why

Question Title

* 8. How long have you been subscribing to eMedical Dermatology Review?

Less than 1 month

2-3 months

4-6 months

More than 6 months

More than a year

Question Title

* 9. Have you referred any colleagues?

1-5

6-10

11-20

More than 20

	Very Interested	Somewhat Interested	Not Interested
The psoralen shortage: current and emerging alternatives for moderate to severe plaque psoriasis	The psoralen shortage: current and emerging alternatives for moderate to severe plaque psoriasis Very Interested	The psoralen shortage: current and emerging alternatives for moderate to severe plaque psoriasis Somewhat Interested	The psoralen shortage: current and emerging alternatives for moderate to severe plaque psoriasis Not Interested
Current and emerging therapies for chronic urticaria and urticarial vasculitis	Current and emerging therapies for chronic urticaria and urticarial vasculitis Very Interested	Current and emerging therapies for chronic urticaria and urticarial vasculitis Somewhat Interested	Current and emerging therapies for chronic urticaria and urticarial vasculitis Not Interested
Innovations in the treatment of actinic keratoses and other nonmelanoma skin cancers	Innovations in the treatment of actinic keratoses and other nonmelanoma skin cancers Very Interested	Innovations in the treatment of actinic keratoses and other nonmelanoma skin cancers Somewhat Interested	Innovations in the treatment of actinic keratoses and other nonmelanoma skin cancers Not Interested
Pediatric dermatology: From eczema to hemangiomas to head lice	Pediatric dermatology: From eczema to hemangiomas to head lice Very Interested	Pediatric dermatology: From eczema to hemangiomas to head lice Somewhat Interested	Pediatric dermatology: From eczema to hemangiomas to head lice Not Interested
Emerging therapies for skin and skin structure infections	Emerging therapies for skin and skin structure infections Very Interested	Emerging therapies for skin and skin structure infections Somewhat Interested	Emerging therapies for skin and skin structure infections Not Interested
Dermatologic emergencies: erythema multiforme spectrum, drug eruptions, ulcerated hemangiomas and others	Dermatologic emergencies: erythema multiforme spectrum, drug eruptions, ulcerated hemangiomas and others Very Interested	Dermatologic emergencies: erythema multiforme spectrum, drug eruptions, ulcerated hemangiomas and others Somewhat Interested	Dermatologic emergencies: erythema multiforme spectrum, drug eruptions, ulcerated hemangiomas and others Not Interested
Dermatologic infestations: treating bed bugs, lice, scabies, fleas and other "big bugs"	Dermatologic infestations: treating bed bugs, lice, scabies, fleas and other "big bugs" Very Interested	Dermatologic infestations: treating bed bugs, lice, scabies, fleas and other "big bugs" Somewhat Interested	Dermatologic infestations: treating bed bugs, lice, scabies, fleas and other "big bugs" Not Interested
New and ongoing developments in acne treatment	New and ongoing developments in acne treatment Very Interested	New and ongoing developments in acne treatment Somewhat Interested	New and ongoing developments in acne treatment Not Interested
Alopecia areata: diagnosis and management	Alopecia areata: diagnosis and management Very Interested	Alopecia areata: diagnosis and management Somewhat Interested	Alopecia areata: diagnosis and management Not Interested
Current status of biologics for treating psoriasis: efficacy and safety	Current status of biologics for treating psoriasis: efficacy and safety Very Interested	Current status of biologics for treating psoriasis: efficacy and safety Somewhat Interested	Current status of biologics for treating psoriasis: efficacy and safety Not Interested
Complementary and alternative therapies in dermatology	Complementary and alternative therapies in dermatology Very Interested	Complementary and alternative therapies in dermatology Somewhat Interested	Complementary and alternative therapies in dermatology Not Interested
Current topics in cosmeceuticals	Current topics in cosmeceuticals Very Interested	Current topics in cosmeceuticals Somewhat Interested	Current topics in cosmeceuticals Not Interested
New therapeutic approaches to infantile hemangiomas	New therapeutic approaches to infantile hemangiomas Very Interested	New therapeutic approaches to infantile hemangiomas Somewhat Interested	New therapeutic approaches to infantile hemangiomas Not Interested
Current methods in sclerotherapy	Current methods in sclerotherapy Very Interested	Current methods in sclerotherapy Somewhat Interested	Current methods in sclerotherapy Not Interested
Aging skin: addressing patients' concerns	Aging skin: addressing patients' concerns Very Interested	Aging skin: addressing patients' concerns Somewhat Interested	Aging skin: addressing patients' concerns Not Interested

	Very Confident	Moderately Confident	Need More Information
The psoralen shortage: current and emerging alternatives for moderate to severe plaque psoriasis	The psoralen shortage: current and emerging alternatives for moderate to severe plaque psoriasis Very Confident	The psoralen shortage: current and emerging alternatives for moderate to severe plaque psoriasis Moderately Confident	The psoralen shortage: current and emerging alternatives for moderate to severe plaque psoriasis Need More Information
Current and emerging therapies for chronic urticaria and urticarial vasculitis	Current and emerging therapies for chronic urticaria and urticarial vasculitis Very Confident	Current and emerging therapies for chronic urticaria and urticarial vasculitis Moderately Confident	Current and emerging therapies for chronic urticaria and urticarial vasculitis Need More Information
Innovations in the treatment of actinic keratoses and other nonmelanoma skin cancers	Innovations in the treatment of actinic keratoses and other nonmelanoma skin cancers Very Confident	Innovations in the treatment of actinic keratoses and other nonmelanoma skin cancers Moderately Confident	Innovations in the treatment of actinic keratoses and other nonmelanoma skin cancers Need More Information
Pediatric dermatology: From eczema to hemangiomas to head lice	Pediatric dermatology: From eczema to hemangiomas to head lice Very Confident	Pediatric dermatology: From eczema to hemangiomas to head lice Moderately Confident	Pediatric dermatology: From eczema to hemangiomas to head lice Need More Information
Emerging therapies for skin and skin structure infections	Emerging therapies for skin and skin structure infections Very Confident	Emerging therapies for skin and skin structure infections Moderately Confident	Emerging therapies for skin and skin structure infections Need More Information
Dermatologic emergencies: erythema multiforme spectrum, drug eruptions, ulcerated hemangiomas and others	Dermatologic emergencies: erythema multiforme spectrum, drug eruptions, ulcerated hemangiomas and others Very Confident	Dermatologic emergencies: erythema multiforme spectrum, drug eruptions, ulcerated hemangiomas and others Moderately Confident	Dermatologic emergencies: erythema multiforme spectrum, drug eruptions, ulcerated hemangiomas and others Need More Information
Dermatologic infestations: treating bed bugs, lice, scabies, fleas and other "big bugs"	Dermatologic infestations: treating bed bugs, lice, scabies, fleas and other "big bugs" Very Confident	Dermatologic infestations: treating bed bugs, lice, scabies, fleas and other "big bugs" Moderately Confident	Dermatologic infestations: treating bed bugs, lice, scabies, fleas and other "big bugs" Need More Information
New and ongoing developments in acne treatment	New and ongoing developments in acne treatment Very Confident	New and ongoing developments in acne treatment Moderately Confident	New and ongoing developments in acne treatment Need More Information
Alopecia areata: diagnosis and management	Alopecia areata: diagnosis and management Very Confident	Alopecia areata: diagnosis and management Moderately Confident	Alopecia areata: diagnosis and management Need More Information
Current status of biologics for treating psoriasis: efficacy and safety	Current status of biologics for treating psoriasis: efficacy and safety Very Confident	Current status of biologics for treating psoriasis: efficacy and safety Moderately Confident	Current status of biologics for treating psoriasis: efficacy and safety Need More Information
Complementary and alternative therapies in dermatology	Complementary and alternative therapies in dermatology Very Confident	Complementary and alternative therapies in dermatology Moderately Confident	Complementary and alternative therapies in dermatology Need More Information
Current topics in cosmeceuticals	Current topics in cosmeceuticals Very Confident	Current topics in cosmeceuticals Moderately Confident	Current topics in cosmeceuticals Need More Information
New therapeutic approaches to infantile hemangiomas	New therapeutic approaches to infantile hemangiomas Very Confident	New therapeutic approaches to infantile hemangiomas Moderately Confident	New therapeutic approaches to infantile hemangiomas Need More Information
Current methods in sclerotherapy	Current methods in sclerotherapy Very Confident	Current methods in sclerotherapy Moderately Confident	Current methods in sclerotherapy Need More Information
Aging skin: addressing patients' concerns	Aging skin: addressing patients' concerns Very Confident	Aging skin: addressing patients' concerns Moderately Confident	Aging skin: addressing patients' concerns Need More Information

Question Title

* 1. Please indicate your specialty:

Question Title

* 2. Over the last year we have covered a number of topics relevant to caring for patients with Medical Dermatologic conditions. Please rate each of the following based on the value of the information presented with respect to clinical practice:

Question Title

* 3. For each of the following, what changes have you made in your practice, based on information gained from eMedical Dermatology Review?

Question Title

* 4. As we develop our topics for the next volume, how interested are you in learning more about the following subjects:

Question Title

* 5. Please indicate your level of clinical confidence in these topics:

Question Title

* 6. What are your preferred learning formats?

Question Title

* 7. Have you listened to our eMedical Dermatology Review podcasts?

Question Title

* 8. How long have you been subscribing to eMedical Dermatology Review?

Question Title

* 9. Have you referred any colleagues?

Question Title

* 10. One more question. Tell us what you like, don't like or what we could do better here at eMedical Dermatology Review. Thank you!